Alexander Putnam Cole, MD

Articles by Alexander Putnam Cole, MD

Dr Cole on the Rationale for Investigating Race-based Disparities in Prostate Cancer–Specific Survival

May 18th 2023

Alexander Putnam Cole, MD, discusses the rationale for investigating the magnitude of racial and ethnic disparities in prostate cancer–specific survival in patients undergoing surgery vs radiotherapy.

Dr Cole on Race-Based Differences in Prostate Cancer–Specific Mortality

ByAlexander Putnam Cole, MD

May 5th 2023

Alexander Putnam Cole, MD, discusses findings from a study investigating the effect of type of definitive treatment on race-based differences in prostate cancer–specific mortality in patients with prostate cancer.

Alexander Putnam Cole, MD

Articles by Alexander Putnam Cole, MD

Dr Cole on the Rationale for Investigating Race-based Disparities in Prostate Cancer–Specific Survival

Dr Cole on Race-Based Differences in Prostate Cancer–Specific Mortality

Latest Updated Articles

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma

Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD

Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma